Not applicableStudy completedNCT01641952
What this trial is testing
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 505